Federated Hermes
PVLA

Federated Hermes’s Palvella Therapeutics PVLA Stock Holding History

Federated Hermes’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54M Buy
433,015
+64,977
+18% +$6.78M 0.09% 242
2025
Q4 		$38.5M Buy
368,038
+28,991
+9% +$2.47M 0.06% 313
2025
Q3 		$21.3M Buy
+339,047
New +$15.1M 0.04% 414
2019
Q4 		– Sell
-404
Closed -$112K – 2156
2019
Q3 		$110K Buy
+404
New +$156K ﹤0.01% 1652
2018
Q3 		– Sell
-9
Closed -$4K – 2336
2018
Q2 		$4K Sell
9
-25
-74% -$11.9K ﹤0.01% 2049
2018
Q1 		$19K Sell
34
-1
-3% -$619 ﹤0.01% 1775
2017
Q4 		$21K Buy
+35
New +$16.3K ﹤0.01% 1764
2017
Q3 		– Sell
-7
Closed -$3K – 2203
2017
Q2 		$3K Buy
+7
New +$2.05K ﹤0.01% 2018

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return